These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29527921)

  • 21. Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth.
    Liang S; Guo R; Zhang Z; Liu D; Xu H; Xu Z; Wang X; Yang L
    Oncol Rep; 2013 Jun; 29(6):2422-30. PubMed ID: 23588929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
    Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
    Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homeodomain proteins and eukaryotic translation initiation factor 4E (eIF4E): an unexpected relationship.
    Topisirovic I; Borden KL
    Histol Histopathol; 2005 Oct; 20(4):1275-84. PubMed ID: 16136508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors.
    Larsson O; Li S; Issaenko OA; Avdulov S; Peterson M; Smith K; Bitterman PB; Polunovsky VA
    Cancer Res; 2007 Jul; 67(14):6814-24. PubMed ID: 17638893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique binding mode of the eukaryotic translation initiation factor 4E for guiding the design of novel peptide inhibitors.
    Di Marino D; D'Annessa I; Tancredi H; Bagni C; Gallicchio E
    Protein Sci; 2015 Sep; 24(9):1370-82. PubMed ID: 26013047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53.
    Zhu N; Gu L; Findley HW; Zhou M
    Biochem Biophys Res Commun; 2005 Oct; 335(4):1272-9. PubMed ID: 16112647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
    Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
    RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct recruitment of human eIF4E isoforms to processing bodies and stress granules.
    Frydryskova K; Masek T; Borcin K; Mrvova S; Venturi V; Pospisek M
    BMC Mol Biol; 2016 Aug; 17(1):21. PubMed ID: 27578149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL.
    De Falco F; Sabatini R; Del Papa B; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Screpanti I; Marconi P; Rosati E
    Oncotarget; 2015 Jun; 6(18):16559-72. PubMed ID: 26041884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.
    Diab-Assaf M; Abou-Khouzam R; Saadallah-Zeidan N; Habib K; Bitar N; Karam W; Liagre B; Harakeh S; Azar R
    Int J Clin Exp Pathol; 2015; 8(1):404-13. PubMed ID: 25755728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The alveolate translation initiation factor 4E family reveals a custom toolkit for translational control in core dinoflagellates.
    Jones GD; Williams EP; Place AR; Jagus R; Bachvaroff TR
    BMC Evol Biol; 2015 Feb; 15(1):14. PubMed ID: 25886308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
    Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
    Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
    Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
    Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
    Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
    Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.
    Attar-Schneider O; Pasmanik-Chor M; Tartakover-Matalon S; Drucker L; Lishner M
    Oncotarget; 2015 Feb; 6(6):4315-29. PubMed ID: 25717031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
    Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
    Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The eukaryotic translation initiation factor eIF4E reprograms alternative splicing.
    Ghram M; Morris G; Culjkovic-Kraljacic B; Mars JC; Gendron P; Skrabanek L; Revuelta MV; Cerchietti L; Guzman ML; Borden KLB
    EMBO J; 2023 Apr; 42(7):e110496. PubMed ID: 36843541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the oncogene eIF4E in cancer: From the bench to clinical trials.
    Borden KL
    Clin Invest Med; 2011 Dec; 34(6):E315. PubMed ID: 22129918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
    Inamdar KV; Romaguera JE; Drakos E; Knoblock RJ; Garcia M; Leventaki V; Medeiros LJ; Rassidakis GZ
    Cancer; 2009 Oct; 115(20):4727-36. PubMed ID: 19708031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small-molecule induction of phospho-eIF4E sumoylation and degradation via targeting its phosphorylated serine 209 residue.
    Gu Y; Zhou H; Gan Y; Zhang J; Chen J; Gan X; Li H; Zheng W; Meng Z; Ma X; Wang X; Xu X; Xu G; Lu X; Liang Y; Zhang X; Lu X; Huang W; Xu R
    Oncotarget; 2015 Jun; 6(17):15111-21. PubMed ID: 25915158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.